Institute for Cancer Research Assigned Patent for Mice with Transgene of iBox Peptide Inhibitor of Group B p21-Activated Kinases

Media coverage

• Title	Institute for Cancer Research Assigned Patent for Mice with Transgene of iBox Peptide Inhibitor of Group B p21-Activated Kinases
  Media name/outlet	Targeted News Service
  Country/Territory	United States
  Date	02/11/22
  Persons	Jonathan Chernoff